Post by
TechOne on Mar 12, 2024 1:43pm
Spectral on Linkedin
In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America each year